London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

England’s NHS has launched a groundbreaking “Trojan Horse” therapy for the treatment of myeloma, offering hope for thousands ...

India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...

Bengaluru: In a BSE filing, Syngene International has informed that the company's facility at Semicon Park, Bengaluru has ...

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest.

GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...

During a live event, Matthew Galsky, MD, discussed adjuvant and neoadjuvant treatment approaches for muscle-invasive bladder ...

Donegal High School held its commencement June 5. The graduates are: Ayomikun Rehoboth Akinrinwoye, Maria Gabriela Aleman ...